NEW YORK, Sept. 13, 2017 /PRNewswire/ -- Global Brain Tumor Diagnosis and Treatments Market: Overview
This report on brain tumor diagnosis and treatments market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of brain tumor diagnosis and treatments as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global brain tumor diagnosis and treatments market with respect to the leading market segments based on major products type segment, diagnosis type, treatment type and geographies. Read the full report: https://www.reportlinker.com/p05098931Global Brain Tumor Diagnosis and Treatments Market: Segmentation
Based on the product type, the brain tumor diagnosis and treatments market has been segmented into: primary brain tumors (meningioma, gliomas, astrocytomas, pituitary tumors and others) and secondary brain tumors. Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of brain tumors incidences worldwide, technological advancement, and growing number of use of brain tumor diagnosis and treatments in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year. Global Brain Tumor Diagnosis and Treatments Market: Key Research Aspects
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the brain tumor diagnosis and treatments market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global Brain Tumor Diagnosis and Treatments market. Geographically, brain tumor diagnosis and treatments market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter's five forces analysis, value chain analysis, and heat map analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global brain tumor diagnosis and treatments market.
Global Brain Tumor Diagnosis and Treatments Market: Competitive Landscape
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global brain tumor diagnosis and treatments market. The report also profiles key players operating in the brain tumor diagnosis and treatments market which are AstraZeneca, Carestream Health, GE Healthcare, Hitachi Medical Corporation, Merck & Co., Inc., Philips Healthcare, Pfizer, Inc., Shimadzu Corporation, Siemens Healthineers, Toshiba Medical Systems Corporation and other prominent players. The global brain tumor diagnosis and treatments market is segmented as follows:
Brain Tumor Diagnosis and Treatments Market, by Product Type
Primary Brain Tumor Meningioma Gliomas Astrocytomas Pituitary Tumors Others Secondary Brain Tumor Brain Tumor Diagnosis and Treatments Market, by Diagnosis Type
CT Scan MRI PET-CT Scan Molecular Testing EEG Others Brain Tumor Diagnosis and Treatments Market, by Treatment Type
Surgery Radiation Therapy Targeted Therapy Chemotherapy Immunotherapy Brain Tumor Diagnosis and Treatments Market, by Geography
North America
U.S. Canada
Europe
Germany
Spain
France
U.K. Italy
Rest of Europe
Asia Pacific
China
India
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
Rest of Middle East & AfricaRead the full report: https://www.reportlinker.com/p05098931
About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/brain-tumor-diagnosis-and-treatments-market-and-secondary-brain-tumor---global-industry-analysis-size-share-growth-trends-and-forecast-2017---2025-300519130.html
SOURCE Reportlinker
